We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$991M
AUM Growth
+$260M
Cap. Flow
+$254M
Cap. Flow %
25.68%
Top 10 Hldgs %
35.1%
Holding
398
New
299
Increased
7
Reduced
3
Closed
88

Top Buys

Rank Stock Value
1
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$27.1M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$17.5M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$17M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$16.3M
5
IMVT icon
Immunovant
IMVT
+$12.8M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$17.7M
2
GPRE icon
Green Plains
GPRE
+$14.3M
3
NMCI
Navios Maritime Containers L.P. Common Units
NMCI
+$12.7M
4
SCOAU
ScION Tech Growth I Unit
SCOAU
+$11.5M
5
CND.U
Concord Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
CND.U
+$11.3M

Sector Composition

Rank Sector Weight
1 Financials 18.61%
2 Healthcare 10.81%
3 Technology 7.09%
4 Industrials 3.76%
5 Consumer Discretionary 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
CALL
Biogen
BIIB
$29.9B
$28.9M 2.91%
+103,200
New +$27.8M
PSTH
2
PUT
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$26.2M 2.65%
+1,092,300
New +$30.6M
PSTH
3
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$23.8M 2.4%
991,600
+968,000
+4,102% +$27.1M
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$17.3M 1.75%
+113,349
New +$17.5M
MIC
5
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$17.2M 1.74%
+542,164
New +$17M
MX icon
6
Magnachip Semiconductor
MX
$128M
$16.4M 1.66%
659,121
+582,970
+766% +$11.4M
CHNG
7
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$15.5M 1.57%
+703,519
New +$16.3M
NMCI
8
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$13.5M 1.36%
1,458,400
-1,849,350
-56% -$12.7M
SEEL
9
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$10.8M 1.09%
+563
New +$6.57M
MUDS
10
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$10.4M 1.05%
+1,062,066
New +$10.7M
CVM icon
11
PUT
CEL-SCI Corp
CVM
$20.6M
$9.88M 1%
+21,663
New +$11.8M
DELL icon
12
Dell
DELL
$283B
$9.85M 0.99%
+220,437
New +$9.03M
SMCI icon
13
Super Micro Computer
SMCI
$19.5B
$9.31M 0.94%
+2,383,660
New +$8.11M
IPHI
14
DELISTED
INPHI CORPORATION
IPHI
$9.26M 0.93%
+51,900
New +$8.67M
RITM icon
15
Rithm Capital
RITM
$5.09B
$9.15M 0.92%
+813,089
New +$8.27M
DISCK
16
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$8.85M 0.89%
+239,864
New +$10.2M
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$121B
$8.29M 0.84%
+38,573
New +$8.47M
RDS.B
18
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$8.25M 0.83%
+223,955
New +$8.55M
UA icon
19
Under Armour Class C
UA
$2.92B
$8.16M 0.82%
+442,334
New +$7.78M
TMTS
20
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
$7.82M 0.79%
793,660
+302,998
+62% +$3.08M
IMVT icon
21
Immunovant
IMVT
$8.09B
$7.79M 0.79%
+485,368
New +$12.8M
HCAR
22
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$7.77M 0.78%
+802,640
New +$8.04M
GPGI
23
GPGI Inc
GPGI
$4.06B
$7.77M 0.78%
+939,673
New +$8M
PCG icon
24
PG&E
PCG
$47.8B
$7.39M 0.75%
+631,163
New +$7.33M
ASLN
25
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$7.3M 0.74%
+54,452
New +$6.9M
1
2 3 4 5

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Mangrove Partners held 398 positions worth $991M, up 36% from $731M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mangrove Partners deployed $254M of net new capital in Q1 2021, opening 299 new positions and adding to 7 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 7.8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Navios Maritime Containers L.P. Common Units, an estimated $12.7M trimmed.

  • Mangrove Partners's largest Q1 2021 buy was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q1 2021, an estimated $27.1M increase.
  • Mangrove Partners's biggest Q1 2021 reduction was Navios Maritime Containers L.P. Common Units, cutting an estimated $12.7M.
  • Mangrove Partners fully exited TG Therapeutics in Q1 2021, selling an estimated $17.7M.
  • Mangrove Partners's ten largest holdings make up 35% of its $991M portfolio in Q1 2021.
  • Mangrove Partners opened 299 new positions and closed 88 in Q1 2021.
  • Mangrove Partners's portfolio value rose 36% quarter-over-quarter to $991M.

Based on Mangrove Partners's 13F filing for Q1 2021, filed 17 May 2021.